CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Short Interest Update
by Doug Wharley · The Cerbat GemCSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) saw a significant decline in short interest in the month of February. As of February 13th, there was short interest totaling 2,966 shares, a decline of 24.8% from the January 29th total of 3,944 shares. Based on an average trading volume of 6,547 shares, the days-to-cover ratio is currently 0.5 days. Based on an average trading volume of 6,547 shares, the days-to-cover ratio is currently 0.5 days.
CSPC Pharmaceutical Group Price Performance
Shares of OTCMKTS:CSPCY traded down C$0.34 during trading on Tuesday, hitting C$4.66. 717 shares of the stock traded hands, compared to its average volume of 5,693. The company has a fifty day moving average price of C$4.89 and a two-hundred day moving average price of C$4.67. CSPC Pharmaceutical Group has a 52-week low of C$2.31 and a 52-week high of C$5.83.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.
The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.